Clinical Trial Update: A Phase 3 Study of Talaporfin Sodium and Interstitial Light Emitting Diodes Treating Hepatocellular Carcinoma (HCC) [Phase 3]

View source ↗

Summary

Phase 3 trial investigating talaporfin sodium with interstitial LED therapy for hepatocellular carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• talaporfin sodium (talaporfin sodium)

Snippet

Sponsor: Light Sciences Oncology | Conditions: Carcinoma, Hepatocellular, Liver Neoplasms | Phase 3 | Status: COMPLETED